Journals / MN Oftalmoloji / 2012 / Cilt: 19 - Sayı: 4

Clinical features of patients with Fuchs’ uveitis syndrome

Fuchs’ üveit sendromlu hastalarımızın klinik özellikleri

Pages
228–230
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FUS must be considered in young patients with difuse keratic presipitates, unilateral cataract and vitreus cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Fuchs’ Uveitis Syndrome (FUS) is a chronic disease, characterized with mild intraocular inflammation without posterior synchecia, iris atrophy, typical keratic preciptates.
📊
Key Findings & Data:Material and Method: We retrospectively analyzed the records of 19 patients with FUS presented to our clinic between 2009-2011.
💡
Conclusion & Impact:FUS must be considered in young patients with difuse keratic presipitates, unilateral cataract and vitreus cells.
🔬Design:Research Article
📍Scope:2009-2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Fuchs’ Uveitis Syndrome (FUS) is a chronic disease, characterized with mild intraocular inflammation without posterior synchecia, iris atrophy, typical keratic preciptates. In our study, we evaluated the demographic and clinical features of our patients with FUS. Material and Method: We retrospectively analyzed the records of 19 patients with FUS presented to our clinic between 2009-2011. FUS diagnosis was based upon clinical findings. Complications were noted during follow-up Results: Six (31.5%) patients were female and 13 (68.5%) were male. Mean age was 31.2+9.2 years at presentation. Bilateral involvement was seen in 3 (15.7%) patients. The most common clinical findings at presentation were diffuse keratic precipitates, diffuse iris atrophy and vitreus cells. During follow-up cataract surgery was performed to 6 eyes (27%) and trabeculectomy performed to 1 (5%) eye. Conclusions: Diffuse iris atrophy was seen more common than heterochromia in patients with FUS. The most common complication was cataract formation. FUS must be considered in young patients with difuse keratic presipitates, unilateral cataract and vitreus cells.

Özet

Giriş: Fuchs’ Üveit Sendromu (FÜS), hafif intraoküler enflamasyonla karakterize heterokromi, iris atrofisi veya ikisinin beraber görüldüğü, tipik keratik presipitatların bulunduğu, arka yapışıklıkların görülmediği, kronik bir hastalıktır. Çalışmamızda FÜS’lu hastalarımızın demografik ve klinik özellikleri değerlendirilmektedir. Gereç ve Yöntem: 2009-2011 yılları arasında kliniğimize başvuran 19 Fuchs’ Üveit Sendromlu hastanın kayıtları tarandı. FÜS tanısı klinik olarak kondu. Takip sırasında gelişen komplikasyonlar not edildi. Bulgular: Hastaların 6’sı (%31,5) kadın, 13’ü (%68,5) erkekti. Başvuru sırasında yaş ortalaması 31,2+9,2 yıldı. Hastaların 3’ünde (%15,7) bilateral tutulum mevcuttu. Başvuruda en sık eşlik eden klinik bulgular difüz keratik presipitatlar, difüz iris atrofisi ve vitreus hücresi idi. Takibimiz sırasında 6 göze (%27) katarakt cerrahisi 1 (%5) göze trabekülektomi yapıldı. Sonuç: Fuchs’ üveit sendromulu hastalarda difüz iris atrofisi, heterokromiden daha sık görülmektedir. En sık görülen komplikasyon katarakt gelişimidir. Genç hastalarda difüz keratik presipitat, unilateral katarakt ve vitreusta hücre varlığında FÜS akla gelmelidir

🔖

Cite This Article

GÜNEY, E., SEZGİN, B. İ. A., AKÇALI, G., ÜNLÜ, C., ERDOĞAN, M. G., BOZKURT, T. K. (2012). Clinical features of patients with Fuchs’ uveitis syndrome. MN Oftalmoloji, Cilt: 19 - Sayı: 4, 228–230. https://ajindex.com/articles/295761

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kazokoglu H, Onal S, Tugal-Tutkun et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol 2008;15:285-93
  2. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 2007;55:173-83
  3. Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol 2005; 16:356-63
  4. De Visser L, Braakenburg A, Rothova A, de Boer JH. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol 2008;146:292-7
  5. Tugal-Tutkun I, Güney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol 2009;148:510-5 6. Velilla S, Dios E, Herreras JM, Calonge M. Fuchs' heterochro - mic iridocyclitis: a review of 26 cases. Ocul Immunol Inflamm 2001;9:169-75 7. Arellanes-García L, del Carmen Preciado-Delgadillo M, Recillas-Gispert C Fuchs' heterochromic iridocyclitis: Clinical manifestations in dark-eyed Mexican patients. Ocul Immunol Inflamm 2002;10:125-31
  6. Norrsell K, Sjödell L. Fuchs' heterochromic uveitis: a longitudinal clinical study. Acta Ophthalmol 2008; 86:58-64
  7. Yang P, Fang W, Jin H, Li B, Chen X, Kijlstra A. Clinical features of Chinese patients with Fuchs’ syndrome. Ophthalmology 2006;113:473-80
  8. Fearnley IR, Rosenthal AR. Fuchs’ heterochromic iridocyclitis revisited. Acta Ophthalmol Scand 1995;73:166-70
  9. Bouchenaki N, Herbort CP. Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay. Middle East Afr J Ophthalmol 2009;16:239-44 12. Tejwani S, Murthy S, Sangwan VS. Cataract extraction outcomes in patients with Fuchs’ heterochromic cyclitis. J Cataract Refract Surg 2006;32:1678-82